Windlas Biotech informs about conference call

05 Nov 2022 Evaluate
Pursuant to Clause 15 of Schedule III, Part A, Para A read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that the conference call to discuss financial performance of the Company for the quarter ended September 30, 2022 is scheduled to be held as per the details enclosed.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

839.90 7.20 (0.86%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×